Aspex Management (HK)’s Prenetics Global PRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-346,150
Closed -$6.69M 31
2026
Q1
$6.69M Hold
346,150
0.1% 25
2025
Q4
$5.45M Hold
346,150
0.11% 21
2025
Q3
$4.6M Hold
346,150
0.1% 23
2025
Q2
$2.95M Hold
346,150
0.06% 22
2025
Q1
$1.36M Hold
346,150
0.03% 27
2024
Q4
$2.01M Hold
346,150
0.05% 29
2024
Q3
$1.39M Hold
346,150
0.04% 27
2024
Q2
$2.05M Hold
346,150
0.04% 34
2024
Q1
$1.4M Hold
346,150
0.04% 30
2023
Q4
$2.05M Hold
346,150
0.06% 31
2023
Q3
$2.52M Hold
346,150
0.08% 26
2023
Q2
$4.62M Hold
346,150
0.13% 26
2023
Q1
$4.99M Hold
346,150
0.12% 32
2022
Q4
$10.4M Hold
346,150
0.29% 26
2022
Q3
$19.6M Hold
346,150
0.58% 21
2022
Q2
$21M Buy
+346,150
New +$24.7M 0.53% 22

Other funds holding PRE

Aspex Management (HK)'s PRE Position: Q2 2026 in Review

Aspex Management (HK) sold out of Prenetics Global (PRE) in Q2 2026, closing a stake of 346,150 shares — an estimated $6.69M sold.

Aspex Management (HK) first reported a position in PRE in Q2 2022 and held it in 16 quarters. The position peaked at $21M in Q2 2022. 25 funds tracked by Wall St. Rank hold PRE as of Q2 2026.

  • Aspex Management (HK) reported no remaining Prenetics Global position as of Q2 2026 after selling out during the quarter.
  • Aspex Management (HK) sold 346,150 Prenetics Global shares in Q2 2026, an estimated $6.69M.
  • Aspex Management (HK) first reported a position in Prenetics Global in Q2 2022 and held it in 16 quarters.
  • Aspex Management (HK)'s Prenetics Global position peaked at $21M in Q2 2022.
  • 25 funds tracked by Wall St. Rank held Prenetics Global as of Q2 2026.

Based on Aspex Management (HK)'s 13F filing for Q2 2026, filed 14 Aug 2026.